COVID-19 has been declared a global pandemic by WHO. The disease is transmitted when the SARS-CoV-2 virus infects the respiratory…
Watch NowSearch results: “Arg”
Showing 85–96 of 136 results
Cell-based reporter gene assays are a well-established screening modality for developing drugs that target diverse signaling pathways.
Watch NowGPCRs are privileged drug targets. Approximately 100 receptors still escape from the drug discovery process as they are orphans, without…
Watch NowTherapeutics targeting glucagon-like peptide, GLP-1 and GLP-2, receptors are being developed to address globally prevalent medical disorders for managing diabetes,…
Watch NowThe webinar addresses the challenge that much of the GPCR druggable space remains untapped for potential therapeutic targets. To address…
Watch NowDiscoveRx’s PathHunter® platform is a simple, cell-based, chemiluminescent assay format that allows for screening large numbers of small molecules or…
Read MoreA common feature of 7TM receptors is that upon activation, the receptors are bound by cellular Arrestin proteins. DiscoveRx has…
Read MoreBiologics represents one of the fastest growing classes of biopharmaceutical molecules today. One of the major bottlenecks in the development…
Read MoreMonoclonal antibodies (MAbs) represent one of the fastest growing classes of biotherapeutic molecules today. While many technologies exist for generating…
Read MoreThere is an increasing need to generate therapeutics targeting metabolic and gastrointestinal diseases to address the global burden of metabolic…
Read MoreKinase therapeutics includes both monoclonal antibodies (mAbs) and small-molecule inhibitors. DiscoveRx’s PathHunter® protein: protein interaction system uses well-established Enzyme Fragment…
Read MoreOrphan GPCRs continue to represent a target class with immense potential for the discovery of novel therapeutic compounds. In spite…
Read More